Study on the effectiveness and safety of BIC/FTC/TAF in adult HIV-1 patients in China: A retrospective real-world cohort study

Authors :: Xiaoxin Xie
Lin Gan
Yanhua Fu
Xiaoyan Yang
Hai Long
Publication Year :: 2022
Publisher :: Research Square Platform LLC, 2022.
Abstract: Background To evaluate the therapeutic effect and tolerance of BIC/FTC/TAF used for 24-week in ART-naïve in China. Methods This single-center retrospective cohort study included ART-naïve who received BIC/FTC/TAF from July 2021 to April 2022. The proportion of patients with HIV RNA

Full Text Access

Tools